DK1893620T3 - Substituerede spiroforbindelser og disses anvendelse til fremstilling af smertestillende lægemidler - Google Patents

Substituerede spiroforbindelser og disses anvendelse til fremstilling af smertestillende lægemidler

Info

Publication number: DK1893620T3
Authority: DK; Denmark
Prior art keywords: aliphatic compound; gen; optionally substituted; cycloaliphatic group; diastereomer
Prior art date: 2005-05-19

Application number

DK06742950.6T

Other languages

English (en)

Inventor

Hans Schick

Robert Frank

Melanie Reich

Ruth Jostock

Gregor Bahrenberg

Fritz Theil

Birgitta Henkel

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-05-19

Filing date

2006-05-17

Publication date

2012-01-16

2006-05-17 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2012-01-16 Application granted granted Critical

2012-01-16 Publication of DK1893620T3 publication Critical patent/DK1893620T3/da

Links

150000003413 spiro compounds Chemical class 0.000 title abstract 3
238000004519 manufacturing process Methods 0.000 title 1
150000007824 aliphatic compounds Chemical class 0.000 abstract 6
125000003118 aryl group Chemical group 0.000 abstract 3
125000005842 heteroatom Chemical group 0.000 abstract 3
125000005843 halogen group Chemical group 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
239000012453 solvate Substances 0.000 abstract 2
208000030814 Eating disease Diseases 0.000 abstract 1
208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
208000001953 Hypotension Diseases 0.000 abstract 1
229940122936 Vanilloid receptor 1 agonist Drugs 0.000 abstract 1
230000001195 anabolic effect Effects 0.000 abstract 1
230000000202 analgesic effect Effects 0.000 abstract 1
230000000954 anitussive effect Effects 0.000 abstract 1
230000001539 anorectic effect Effects 0.000 abstract 1
230000001088 anti-asthma Effects 0.000 abstract 1
230000001773 anti-convulsant effect Effects 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000002460 anti-migrenic effect Effects 0.000 abstract 1
230000000648 anti-parkinson Effects 0.000 abstract 1
230000001139 anti-pruritic effect Effects 0.000 abstract 1
239000000924 antiasthmatic agent Substances 0.000 abstract 1
239000001961 anticonvulsive agent Substances 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940005513 antidepressants Drugs 0.000 abstract 1
229960003965 antiepileptics Drugs 0.000 abstract 1
239000000939 antiparkinson agent Substances 0.000 abstract 1
239000003908 antipruritic agent Substances 0.000 abstract 1
229940124584 antitussives Drugs 0.000 abstract 1
230000001966 cerebroprotective effect Effects 0.000 abstract 1
206010061428 decreased appetite Diseases 0.000 abstract 1
PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
208000021822 hypotensive Diseases 0.000 abstract 1
230000001077 hypotensive effect Effects 0.000 abstract 1
239000002955 immunomodulating agent Substances 0.000 abstract 1
229940121354 immunomodulator Drugs 0.000 abstract 1
230000002584 immunomodulator Effects 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
230000000324 neuroprotective effect Effects 0.000 abstract 1
230000001777 nootropic effect Effects 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
229940125725 tranquilizer Drugs 0.000 abstract 1
239000003204 tranquilizing agent Substances 0.000 abstract 1
230000002936 tranquilizing effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Psychology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Nutrition Science (AREA)
Child & Adolescent Psychology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK06742950.6T 2005-05-19 2006-05-17 Substituerede spiroforbindelser og disses anvendelse til fremstilling af smertestillende lægemidler DK1893620T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102005023784A DE102005023784A1 (de)	2005-05-19	2005-05-19	Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
PCT/EP2006/004651 WO2006122769A2 (de)	2005-05-19	2006-05-17	Substituierte spiro-verbindungen und deren verwendung zur herstellung von arzneimitteln gegen schmerz

Publications (1)

Publication Number	Publication Date
DK1893620T3 true DK1893620T3 (da)	2012-01-16

Family

ID=36646208

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06742950.6T DK1893620T3 (da)	2005-05-19	2006-05-17	Substituerede spiroforbindelser og disses anvendelse til fremstilling af smertestillende lægemidler

Country Status (13)

Country	Link
US (1)	US20080214807A1 (da)
EP (2)	EP1893620B1 (da)
JP (1)	JP5376941B2 (da)
AT (1)	ATE524478T1 (da)
CA (1)	CA2608385A1 (da)
CY (1)	CY1112137T1 (da)
DE (1)	DE102005023784A1 (da)
DK (1)	DK1893620T3 (da)
ES (2)	ES2447815T3 (da)
PL (2)	PL2292625T3 (da)
PT (1)	PT1893620E (da)
SI (1)	SI1893620T1 (da)
WO (1)	WO2006122769A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005044813A1 (de)	2005-05-19	2007-10-04	Grünenthal GmbH	Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
EP2064187A2 (en) *	2006-08-25	2009-06-03	Vitae Pharmaceuticals, Inc.	Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
EP2265588B1 (en)	2008-02-27	2013-06-26	Vitae Pharmaceuticals, Inc.	INHIBITORS OF 11ß -HYDROXYSTEROID DEHYDROGENASE TYPE 1
US8349852B2 (en)	2009-01-13	2013-01-08	Novartis Ag	Quinazolinone derivatives useful as vanilloid antagonists
US8765735B2 (en) *	2009-05-18	2014-07-01	Infinity Pharmaceuticals, Inc.	Isoxazolines as inhibitors of fatty acid amide hydrolase
CN102762572A (zh)	2010-02-01	2012-10-31	诺瓦提斯公司	作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
AR080056A1 (es)	2010-02-01	2012-03-07	Novartis Ag	Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en)	2010-02-02	2014-10-15	Novartis AG	Cyclohexyl amide derivatives as crf receptor antagonists
TWI635082B (zh)	2016-01-13	2018-09-11	歌林達有限公司	３－（（雜－）芳基）－８－胺基－２－側氧－１,３－二氮雜－螺－［４.５］－癸烷衍生物
MX378995B (es)	2016-01-13	2025-03-11	Gruenenthal Gmbh	Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
RS60855B1 (sr)	2016-01-13	2020-10-30	Gruenenthal Gmbh	Derivati 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2421797A (en) *	1996-03-15	1997-10-01	Du Pont Pharmaceuticals Company	Spirocycle integrin inhibitors
WO1998043962A1 (en) *	1997-03-28	1998-10-08	Du Pont Pharmaceuticals Company	Heterocyclic integrin inhibitor prodrugs
WO1999058139A2 (en) *	1998-05-08	1999-11-18	The Regents Of The University Of California	Methods for detecting and inhibiting angiogenesis
DE10130020A1 (de) *	2001-06-25	2003-12-04	Gruenenthal Gmbh	Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate
AU2003241453A1 (en) *	2002-05-17	2003-12-02	Janssen Pharmaceutica N.V.	Aminotetralin-derived urea modulators of vanilloid vr1 receptor
JP2005531574A (ja) *	2002-05-22	2005-10-20	アムジエン・インコーポレーテツド	痛みの治療にバニロイド受容体リガンドとして使用するためのアミノ−ピリジン、−ピリジンおよびピリダジン誘導体
DE102004032567A1 (de) *	2004-07-05	2006-03-02	Grünenthal GmbH	Substituierte 1-Propiolyl-piperazine

2005
- 2005-05-19 DE DE102005023784A patent/DE102005023784A1/de not_active Withdrawn
2006
- 2006-05-17 PL PL10012043T patent/PL2292625T3/pl unknown
- 2006-05-17 US US11/914,866 patent/US20080214807A1/en not_active Abandoned
- 2006-05-17 SI SI200631204T patent/SI1893620T1/sl unknown
- 2006-05-17 WO PCT/EP2006/004651 patent/WO2006122769A2/de not_active Ceased
- 2006-05-17 AT AT06742950T patent/ATE524478T1/de active
- 2006-05-17 PT PT06742950T patent/PT1893620E/pt unknown
- 2006-05-17 PL PL06742950T patent/PL1893620T3/pl unknown
- 2006-05-17 EP EP06742950A patent/EP1893620B1/de not_active Expired - Lifetime
- 2006-05-17 JP JP2008511619A patent/JP5376941B2/ja not_active Expired - Fee Related
- 2006-05-17 ES ES10012043.5T patent/ES2447815T3/es not_active Expired - Lifetime
- 2006-05-17 EP EP10012043.5A patent/EP2292625B1/de not_active Expired - Lifetime
- 2006-05-17 CA CA002608385A patent/CA2608385A1/en not_active Abandoned
- 2006-05-17 DK DK06742950.6T patent/DK1893620T3/da active
- 2006-05-17 ES ES06742950T patent/ES2370038T3/es not_active Expired - Lifetime
2011
- 2011-12-05 CY CY20111101204T patent/CY1112137T1/el unknown

Also Published As

Publication number	Publication date
DE102005023784A1 (de)	2006-11-30
ATE524478T1 (de)	2011-09-15
CA2608385A1 (en)	2006-11-23
CY1112137T1 (el)	2015-11-04
EP1893620B1 (de)	2011-09-14
ES2370038T3 (es)	2011-12-12
JP2008540592A (ja)	2008-11-20
EP2292625A1 (de)	2011-03-09
PT1893620E (pt)	2011-10-31
EP2292625B1 (de)	2013-12-25
ES2447815T3 (es)	2014-03-13
WO2006122769A3 (de)	2007-03-15
WO2006122769A2 (de)	2006-11-23
PL1893620T3 (pl)	2012-02-29
SI1893620T1 (sl)	2012-04-30
US20080214807A1 (en)	2008-09-04
EP1893620A2 (de)	2008-03-05
JP5376941B2 (ja)	2013-12-25
PL2292625T3 (pl)	2014-04-30

Publication	Publication Date	Title
CY1112137T1 (el)	2015-11-04	Υποκατεστημενες σπειρο-ενωσεις και η χρηση αυτων για παραγωγη φαρμακευτικων μεσων εναντι πονου
WO2007091948A3 (en)	2007-10-04	Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1
CA2523261A1 (en)	2004-11-18	Fused pyrimidine derivatives with crf activity
WO2004014902A3 (en)	2004-07-08	Compounds having an activity at metabotropic glutamate receptors
CY1109339T1 (el)	2014-07-02	Υποκατεστημενες ενωσεις 1-οξα-3,8-διαζασπειρο[4.5]-δεκαν-2-ονης και η χρησιμοποιηση τους για την παρασκευη φαρμακων
EA200870358A1 (ru)	2009-02-27	2-(циклический амино) пиримидоновые производные в качестве ингибиторов tpk1
EA200400953A1 (ru)	2005-06-30	Замещённые пиридиноны в качестве модуляторов map-киназы p38
MX2007007220A (es)	2007-08-20	Compuestos de pirazolona como agonistas de receptor de glutamato metabotropico para el tratamiento de trastornos neurologicos y psiquiatricos.
EA200501061A1 (ru)	2006-04-28	N-(1-бензил-2-оксо-2-(1-пиперазинил)этил)-1-пиперидинкарбоксамидные производные и родственные соединения в качестве cgrp-антагонистов для лечения головных болей
IL177291A0 (en)	2006-12-10	Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
EA200400762A1 (ru)	2004-12-30	Новые соединения, их использование в медицине, способ их изготовления и содержащие их фармацевтические композиции
Wrobleski et al.	2006	Cyclobutane derivatives as potent NK1 selective antagonists
BRPI0517425A (pt)	2008-10-07	composto ou um sal, solvato, enanciÈmero, diastereÈmero ou mistura de diastereÈmeros do mesmo, composição farmacêutica, uso de composto
SE0102055D0 (sv)	2001-06-08	New Compounds
AR048973A1 (es)	2006-06-14	(4-metoxi-7-morfolin-4-il-benzotiazol-2-il)amida del acido 4-hidroxi-4-metil-piperidin-1-carboxilico. proceso de preparacion y composiciones farmaceuticas
MXPA04005426A (es)	2004-10-11	Derivados de pirazol de anillos fuisionados.
CY1110613T1 (el)	2015-04-29	Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων
MXPA05008186A (es)	2005-10-05	Derivados de quinoxalina saturados y su uso como ligandos receptores de glutamato metabotropico.
DE60134735D1 (de)	2008-08-21	Neue neurokinin-antagonisten zum gebrauch als arzneimittel
MXPA05011521A (es)	2006-01-23	Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
MXPA05011476A (es)	2005-12-12	Imidazolin-2-il-aminofenil-amidas como antagonistas de prostaglandina i2.
SE0403118D0 (sv)	2004-12-21	New compounds 2
ATE420860T1 (de)	2009-01-15	N-substituierte amide als nk1 rezeptor antagonisten
DK1542968T3 (da)	2009-04-20	Fremgangsmåde til fremstilling af mellemforbindelser
Liu et al.	2010	A mild and efficient synthesis of monofluorinated α-lactam pseudopeptides via a novel dehydrofluorination of Ugi products